Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Basedow Disease

1-methyl-3-isobutylxanthine has been researched along with Basedow Disease in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haraguchi, K1
Shimura, H1
Lin, L1
Saito, T1
Endo, T1
Onaya, T1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Basedow Disease

ArticleYear
Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: a possible model cell line of extrathyroidal expression of thyrotropin receptor.
    Biochemical and biophysical research communications, 1996, Jun-05, Volume: 223, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; Animals; Base Sequence; Cell Differentiation; Cyclic AMP; De

1996